Previous Page  150 / 225 Next Page
Information
Show Menu
Previous Page 150 / 225 Next Page
Page Background

150

· DOS Abstracts

Effect of prophylactic high-dose methylpredniso-

lone on postoperative delirium in elderly patients

undergoing hip fracture surgery; a double-blind,

randomised, placebo-controlled trial.

Christopher Clemmesen, Troels Haxholdt Lunn, Morten Tange Kristensen, Henrik

Palm, Nicolai Bang Foss

Department of Anaesthesiology, Hvidovre Hospital; Department of Anaes-

thesiology, Hvidovre Hospital; Departments of Physiotherapy & Orthopaedic

Surgery, Hv; Department of Orthopaedic Surgery, Hvidovre ; Department of

Anaesthesiology, Hvidovre Hospital

Background:

Postoperative delirium is a common complication in elderly pa-

tients after hip fracture surgery. Neuroinflammation due to stress response

might be a key element in the pathophysiological mechanisms to most postop-

erative delirium.

Purpose / Aim of Study:

If prophylactic high single dose methylprednisolone

could attenuate the stress response and thereby lower the severity of postop-

erative delirium in elderly patients after hip fracture surgery.

Materials and Methods:

A randomised, double-blind, placebo-controlled trial.

Patients were aged ≥ 65 years, admitted with hip fracture and able to give in-

formed consent. They were allocated to receive either i.v. methylprednisolone

(125 mg), or placebo as soon as possible after admission and confirmed hip

fracture. The primary outcome was severity of postoperative delirium assessed

once daily with the Confusion Assessment Method delirium severity scoring

system for the first three postoperative days.

Findings / Results:

117 patients were included in modified intention-to- treat

analyses of the primary outcome. There was no significant difference in median

cumulated CAM-S score between the methylprednisolone group (1 [IQR 0-6])

and the placebo group (2 [IQR 0-9.5]), p= 0.294. The incidence of postop-

erative delirium (defined as CAM-S > 5) was significantly lower in the methyl-

prednisolone group (10 out of 59 [16.7%]) compared with the placebo group

(19 out of 58 [31.7%] odds ratio [OR] 2.39, 95%CI 1.00 to 5.72;p=0.048).

The median cumulated postoperative fatigue score was significantly lower in

the methylprednisolone group (5 [IQR 2-6]) compared with the placebo group

(6[IQR 4-8]), p=0.008.

Conclusions:

Prophylactic high-dose methylprednisolone to elderly patients

with hip fracture might have a preventive effect on postoperative delirium and

fatigue after surgery.

No conflicts of interest reported

102.